Activation of transient receptor potential vanilloid 4 involves in hypoxia/reoxygenation injury in cardiomyocytes

Transient receptor potential vanilloid 4 (TRPV4) is highly expressed in heart and vessels and can be activated during myocardial ischemia/reperfusion (I/R). Recently, we found that treatment with a selective TRPV4 antagonist HC-067047 significantly reduced infarct size, decreased troponin T levels a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cell Death Dis
Glavni autori: Wu, Qiong-Feng, Qian, Cheng, Zhao, Ning, Dong, Qian, Li, Jing, Wang, Bin-Bin, Chen, Lei, Yu, Lixiu, Han, Bing, Du, Yi-Mei, Liao, Yu-Hua
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520739/
https://ncbi.nlm.nih.gov/pubmed/28542130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.227
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items